Tag: Diagnostics

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Is The Hepatitis C Testing Market Size Likely To Evolve From 2025 Through 2034?

The hepatitis c testing market has experienced significant growth in recent years. It is forecasted to grow from $1.24 billion in 2024 to $1.32 billion in 2025, with a compound annual growth rate (CAGR) of 6.6%. The expansion observed in the past can be linked to the increased prevalence of hepatitis C, the broadening of public health initiatives, a rise in intravenous drug use, heightened awareness of the dangers associated with hepatitis C, and governmental financial support for infectious disease management.

The hepatitis c testing market size is poised for substantial growth over the next few years. It is projected to expand to $1.68 billion by 2029, achieving a compound annual growth rate (CAGR) of 6.2%. This expected expansion is driven by a rising need for early disease identification, improved access to healthcare, an increasing focus on preventive health, backing from international health organizations, and government efforts towards hepatitis C elimination. Noteworthy trends anticipated during this forecast period involve the widespread use of multiplex diagnostic platforms, the integration of artificial intelligence (AI) in diagnostic instruments, a pivot towards home-based testing kits, greater collaboration for developing new tests, and the introduction of cost-effective testing solutions.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24559&type=smp

What Are The Key Drivers Of Growth In The Hepatitis C Testing Market?

The increasing occurrence of hepatitis cases is anticipated to drive the expansion of the hepatitis C testing market moving forward. Hepatitis C, a viral infection, leads to liver inflammation and has the potential for severe liver damage if not addressed. The surge in hepatitis cases primarily stems from low vaccination coverage, which leaves numerous people vulnerable and aids in the virus’s dissemination. Testing for Hepatitis C enables early identification of the virus, allowing for timely treatment to prevent liver damage and severe health issues. Furthermore, it pinpoints infected persons, aiding in containment of the spread and improving management of the disease. For example, data from April 2024 by the World Health Organization (WHO), a Switzerland-based intergovernmental body focused on global public health, indicates that more than 50 million individuals worldwide are affected by chronic hepatitis C virus infection, with about 1.0 million new cases reported annually. Consequently, the growing frequency of hepatitis cases is fueling the expansion of the hepatitis C testing market.

What Are The Major Segment Categories Driving The Hepatitis C Testing Market Growth?

The hepatitis c testing market covered in this report is segmented –

1) By Type: Antibody Tests, Nucleic Acid Tests, Genotyping Tests

2) By Product: Test Kits, Instruments, Reagents, Consumables

3) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests, Polymerase Chain Reaction, Next-Generation Sequencing

4) By Application: Blood Screening, Viral Load Monitoring, Disease Diagnosis

5) By End-User: Hospital-Based Laboratories, Stand-Alone Laboratories, Other End-Users

Subsegments:

1) By Antibody Tests: Enzyme Immunoassay (EIA), Recombinant Immunoblot Assay (RIBA), Rapid Diagnostic Tests (RDTs)

2) By Nucleic Acid Tests (NATs): Quantitative Ribonucleic Acid (RNA) Tests, Qualitative Ribonucleic Acid (RNA) Tests, Transcription-Mediated Amplification (TMA), Reverse Transcription Polymerase Chain Reaction (RT-PCR)

3) By Genotyping Tests: Line Probe Assay (LiPA), Sequencing-Based Assay, Real-Time Polymerase Chain Reaction (PCR)-Based Genotyping

Which Ongoing Trends Are Expected To Shape The Hepatitis C Testing Market Outlook?

Major companies within the hepatitis C testing market are concentrating on developing advanced solutions, such as dual antigen-antibody diagnostic tests, to enable more effective screening and monitoring of the infection. An antigen-antibody diagnostic test identifies both viral proteins (antigens) and immune response proteins (antibodies) to pinpoint both active and past infections. This combined approach provides a comprehensive evaluation of the infection status. For instance, in July 2023, Roche Diagnostics India Pvt. Ltd., an India-based provider of diagnostic tests and systems, introduced Elecsys HCV Duo. This fully automated immunoassay is capable of simultaneously and independently detecting both HCV antigens and antibodies from a single plasma or serum sample. This innovation facilitates early diagnosis, supports patient management, and aligns with India’s national strategy to eliminate hepatitis C through timely and comprehensive screening.

Which Industry Leaders Are Driving Innovation Across The Hepatitis C Testing Market?

Major companies operating in the hepatitis c testing market are F. Hoffmann-La Roche Ltd., Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Hologic Inc., QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., SD Biosensor INC., QIAGEN N.V., DiaSorin S.p.A., Cepheid, Abcam Plc, OraSure Technologies Inc., Meridian Bioscience Inc., Trivitron Healthcare Private Limited, General Biologicals Corporation, Biogate Laboratories Ltd., Cosara Diagnostics Private Limited, BioGenex Life Sciences Private Limited, BIOGENIX INC. PVT. LTD.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/hepatitis-c-testing-global-market-report

What Are The Key Regional Factors Influencing The Hepatitis C Testing Market Growth?

North America was the largest region in the hepatitis C testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis c testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Hepatitis C Testing Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24559&type=smp

Browse Through More Reports Similar to the Global Hepatitis C Testing Market 2025, By The Business Research Company

Hepatitis C Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hepatitis-c-global-market-report

Hepatitis Diagnostic Tests Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hepatitis-diagnostic-tests-global-market-report

Covid 19 Rapid Test Kits Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/covid-19-rapid-test-kits-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Current and Projected Market Size of the Hepatitis C Testing Industry?

The market size for hepatitis c testing has seen significant expansion recently. Predictions indicate the marketplace will increase from a value of $1.24 billion in 2024 to $1.32 billion in the following year with a compound annual growth rate (CAGR) of 6.6%. The factors contributing to historical growth include an increase in hepatitis C occurrences, the broadening of public health initiatives, a surge in intravenous drug consumption, heightened awareness of the risks associated with hepatitis C, and government investment for controlling infectious diseases.

The market size for hepatitis C testing is projected to experience robust growth over the next several years, swelling to $1.68 billion in 2029 with a compound annual growth rate (CAGR) of 6.2%. This growth within the projection period can be credited to the rising demand for early detection of the disease, enhanced access to healthcare, a growing focus on preventive healthcare, assistance from worldwide health organizations, and governmental strategies aimed at eradicating hepatitis C. Key trends anticipated during the forecast period embrace the integration of multiplex diagnostic platforms, incorporation of artificial intelligence (AI) into diagnostic tools, a move towards home-based testing kits, heightened collaboration for the development of tests, and the development of cost-effective testing solutions.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24559&type=smp

#Which Factors Are Currently Driving The Growth Of The Hepatitis C Testing Market?

The expansion of the hepatitis C testing market is projected to be driven by the increasing occurrence of hepatitis cases. Hepatitis C is an infection caused by a virus that induces inflammation in the liver and can lead to severe liver damage if ignored. The cause of the rise in hepatitis cases can primarily be attributed to the lack of vaccination among people, thereby making it easier for the virus to disseminate. Testing for Hepatitis C facilitates early detection of the virus, enabling quick treatment to prevent liver damage and severe complications. It also aids in identifying infected persons, which assists in preventing the virus’s transmission and improving disease management. For example, the World Health Organization (WHO) reported in April 2024 that over 50 million people worldwide are living with chronic hepatitis C virus infection, with nearly 1.0 million new infections each year. As a result, the escalating incidence of hepatitis infections is fueling the growth of the hepatitis C testing market.

How Is The Global Hepatitis C Testing Market Structured In Terms Of Segments?

The hepatitis c testing market covered in this report is segmented –

1) By Type: Antibody Tests, Nucleic Acid Tests, Genotyping Tests

2) By Product: Test Kits, Instruments, Reagents, Consumables

3) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests, Polymerase Chain Reaction, Next-Generation Sequencing

4) By Application: Blood Screening, Viral Load Monitoring, Disease Diagnosis

5) By End-User: Hospital-Based Laboratories, Stand-Alone Laboratories, Other End-Users

Subsegments:

1) By Antibody Tests: Enzyme Immunoassay (EIA), Recombinant Immunoblot Assay (RIBA), Rapid Diagnostic Tests (RDTs)

2) By Nucleic Acid Tests (NATs): Quantitative Ribonucleic Acid (RNA) Tests, Qualitative Ribonucleic Acid (RNA) Tests, Transcription-Mediated Amplification (TMA), Reverse Transcription Polymerase Chain Reaction (RT-PCR)

3) By Genotyping Tests: Line Probe Assay (LiPA), Sequencing-Based Assay, Real-Time Polymerase Chain Reaction (PCR)-Based Genotyping

What Trends Are Currently Influencing Growth In The Hepatitis C Testing Market?

Leading businesses in the hepatitis C testing market are concentrating on the creation of cutting-edge solutions such as dual antigen-antibody diagnostic tests, intending to increase the efficiency of screening and monitoring for the infection. This type of test can identify viral proteins, known as antigens, and immune response proteins or antibodies, thus enabling detection of both current and previous infections. This combined method offers a comprehensive assessment of infection status. Roche Diagnostics India Pvt. Ltd., an Indian diagnostic tests and systems company, launched an innovation in this field in July 2023 called Elecsys HCV Duo. This automated immunoassay can independently detect both HCV antigens and antibodies from a single plasma or serum sample, paving the way for prompt diagnosis, facilitating patient care, and aligning with India’s national campaign to eradicate hepatitis C through exhaustive and timely screening.

Who Are The Main Participants Shaping The Hepatitis C Testing Market Landscape?

Major companies operating in the hepatitis c testing market are F. Hoffmann-La Roche Ltd., Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Hologic Inc., QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., SD Biosensor INC., QIAGEN N.V., DiaSorin S.p.A., Cepheid, Abcam Plc, OraSure Technologies Inc., Meridian Bioscience Inc., Trivitron Healthcare Private Limited, General Biologicals Corporation, Biogate Laboratories Ltd., Cosara Diagnostics Private Limited, BioGenex Life Sciences Private Limited, BIOGENIX INC. PVT. LTD.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/hepatitis-c-testing-global-market-report

Which Region Currently Holds The Largest Share In The Hepatitis C Testing Market?

North America was the largest region in the hepatitis C testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis c testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24559&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Hepatitis C Testing Market Grown from 2024 to 2025?

Over the past few years, the market size for hepatitis C testing has significantly amplified. Its growth is predicted to rise from $1.24 billion in 2024, to $1.32 billion in 2025, with a compound annual growth rate (CAGR) of 6.6%. The historic growth can be correlated with the increasing prevalence of hepatitis C, the enlargement of public health initiatives, the escalating use of intravenous drugs, heightened awareness regarding the risks of hepatitis C, and government grants aimed at controlling infectious diseases.

What Growth Rate Is Anticipated for the Hepatitis C Testing Market in the Coming Years?

Expectations are high for the hepatitis c testing market, with predictions suggesting substantial growth in the coming years. By 2029, the market is projected to amass a value of $1.68 billion, propelled by a compound annual growth rate (CAGR) of 6.2%. The expansion in the forecast period is as a result of factors such as the surge in demand for the initial detection of the disease, improved healthcare availability, increased focus on preventive health, support from leading global health organizations, and state-run initiatives aimed at eradicating hepatitis C. Significant trends that are associated with this forecast period encompass the application of multiplex diagnostic platforms, the incorporation of artificial intelligence (AI) into diagnostic instruments, a move towards home-based testing kits, enlarged cooperation for test formulation, and the creation of affordable testing solutions.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24559&type=smp

Who Are the Leading Companies in the Hepatitis C Testing Market?

Major companies operating in the hepatitis c testing market are F. Hoffmann-La Roche Ltd., Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Hologic Inc., QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., SD Biosensor INC., QIAGEN N.V., DiaSorin S.p.A., Cepheid, Abcam Plc, OraSure Technologies Inc., Meridian Bioscience Inc., Trivitron Healthcare Private Limited, General Biologicals Corporation, Biogate Laboratories Ltd., Cosara Diagnostics Private Limited, BioGenex Life Sciences Private Limited, BIOGENIX INC. PVT. LTD.

What Are the Key Drivers of the Hepatitis C Testing Market?

The growth of the hepatitis C testing market is expected to be fuelled by the increasing prevalence of hepatitis cases. Hepatitis C is a viral infection that can cause severe liver damage if left untreated owing to inflammation. The lack of adequate vaccination rates, leaving many people vulnerable to the virus, is the primary reason for the increased hepatitis cases. Hepatitis C testing plays a crucial role in early virus detection, enabling immediate treatment to prevent severe liver damage and complications. Furthermore, it helps identify infected individuals, mitigating the spread of the virus and improving disease control. The World Health Organization (WHO), a Switzerland-based global public health intergovernmental organization, reported in April 2024 that over 50 million people worldwide are living with chronic hepatitis C virus infection. Roughly 1.0 million new infections are reported every year. Consequently, the surging prevalence of hepatitis cases is fuelling the growth of the hepatitis C testing market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24559&type=smp

What Are the Key Market Segments in the Hepatitis C Testing Industry?

The hepatitis c testing market covered in this report is segmented –

1) By Type: Antibody Tests, Nucleic Acid Tests, Genotyping Tests

2) By Product: Test Kits, Instruments, Reagents, Consumables

3) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA), Rapid Diagnostic Tests, Polymerase Chain Reaction, Next-Generation Sequencing

4) By Application: Blood Screening, Viral Load Monitoring, Disease Diagnosis

5) By End-User: Hospital-Based Laboratories, Stand-Alone Laboratories, Other End-Users

Subsegments:

1) By Antibody Tests: Enzyme Immunoassay (EIA), Recombinant Immunoblot Assay (RIBA), Rapid Diagnostic Tests (RDTs)

2) By Nucleic Acid Tests (NATs): Quantitative Ribonucleic Acid (RNA) Tests, Qualitative Ribonucleic Acid (RNA) Tests, Transcription-Mediated Amplification (TMA), Reverse Transcription Polymerase Chain Reaction (RT-PCR)

3) By Genotyping Tests: Line Probe Assay (LiPA), Sequencing-Based Assay, Real-Time Polymerase Chain Reaction (PCR)-Based Genotyping

What Are the Latest Trends in the Hepatitis C Testing Market?

Prominent corporations within the hepatitis C testing market are concentrating on creating improved solutions such as dual antigen-antibody diagnostic assessments for more efficient screening and surveillance of the ailment. The dual antigen-antibody diagnostic examination identifies viral proteins (antigens) and immune response proteins (antibodies) to distinguish between active and previous infections. This methodology provides an in-depth analysis of the infection status. To put it in context, Roche Diagnostics India Pvt. Ltd., a diagnostic tests and systems enterprise based in India, unveiled the Elecsys HCV Duo in July 2023. This fully automated immunoassay can independently and simultaneously detect both HCV antibodies and antigens from a single plasma or serum sample. This revolutionary technique facilitates early detection, aids patient care, and is consistent with India’s national approach to eradicate hepatitis C through comprehensive and prompt screening.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/hepatitis-c-testing-global-market-report

What Are the Key Regional Markets in the Hepatitis C Testing Industry?

North America was the largest region in the hepatitis C testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepatitis c testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24559

This Report Delivers Insight On:

1. How big is the hepatitis c testing market, and how is it changing globally?

2. Who are the major companies in the hepatitis c testing market, and how are they performing?

3. What are the key opportunities and risks in the hepatitis c testing market right now?

4. Which products or customer segments are growing the most in the hepatitis c testing market?

5. What factors are helping or slowing down the growth of the hepatitis c testing market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model